PK5.STU BASILEA PHARMACEU N (PK5.SG)
- Market cap
- -
- P/E
- -
- P/B
- 5.40x
- ROE
- 31.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is PK5.STU undervalued?
Graham numberThe Graham number of BASILEA PHARMACEU N (PK5.SG) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BASILEA PHARMACEU N (PK5.SG) fundamental analysis
No fundamental analysis for BASILEA PHARMACEU N (PK5.SG) yet.
BASILEA PHARMACEU N (PK5.SG) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BASILEA PHARMACEU N (PK5.SG)
There is no Profile data available for PK5.SG.
Full company profileBASILEA PHARMACEU N (PK5.SG) financial statements
BASILEA PHARMACEU N (PK5.SG) annual financial statements (CHF; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 66.0M | 102M | 133M | 134M | 128M | 148M | 148M | 158M | 209M | 232M |
| Gross Profit | 60.6M | 92.5M | 112M | 116M | 104M | 124M | 123M | 131M | 170M | 193M |
| Operating Income | -43.9M | -14.1M | -23.2M | -15.7M | -21.4M | 1.17M | 18.5M | 19.2M | 61.2M | 51.5M |
| EBITDA | - | -10.4M | -22.8M | -14.3M | -5.89M | 2.11M | 23.0M | 23.2M | 66.3M | 51.0M |
| Net Income | -51.3M | -19.4M | -31.4M | -22.4M | -14.7M | -6.83M | 12.1M | 10.5M | 77.6M | 40.2M |
| EPS | - | -1.78 | -2.92 | -2.08 | -1.35 | -0.58 | 1.02 | 0.87 | 6.42 | 3.27 |
| Balance Sheet | ||||||||||
| Total Assets | 328M | 351M | 282M | 221M | 230M | 247M | 221M | 173M | 258M | 282M |
| Total Liabilities | 363M | 393M | 348M | 314M | 332M | 306M | 242M | 183M | 177M | 154M |
| Shareholders' Equity | -35.0M | -41.4M | -66.7M | -93.0M | -102M | -58.6M | -20.7M | -10.0M | 81.0M | 128M |
| Cash & Short-term Investments | 239M | 199M | 173M | 109M | 60.8M | 53.7M | 84.7M | 59.9M | 121M | 160M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -75.0M | 19.0M | -79.2M | -63.8M | -54.1M | -32.0M | 7.06M | 14.2M | 74.4M | 62.1M |
| Capital Expenditure | 431K | 945K | 609K | 404K | 2.27M | 860K | 3.30M | 1.03M | 1.79M | 2.86M |
| Free Cash Flow | - | 18.1M | -79.8M | -64.2M | -56.4M | -32.9M | 3.75M | 13.2M | 72.6M | 59.2M |
| Ratios | ||||||||||
| ROE | - | - | - | - | - | - | - | - | 95.8% | 31.5% |
| ROA | -15.6% | -5.5% | -11.1% | -10.1% | -6.4% | -2.8% | 5.5% | 6.0% | 30.1% | 14.3% |
| Net Profit Margin | -77.7% | -19.1% | -23.7% | -16.7% | -11.5% | -4.6% | 8.2% | 6.6% | 37.2% | 17.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BASILEA PHARMACEU N (PK5.SG) dividends
BASILEA PHARMACEU N (PK5.SG) has not paid dividends in the last 10 fiscal years.
Who owns BASILEA PHARMACEU N (PK5.SG)
Ownership data of BASILEA PHARMACEU N (PK5.SG) is not available yet.
BASILEA PHARMACEU N (PK5.SG) company profile
- Company name
- BASILEA PHARMACEU N (PK5.SG)
- Ticker
- PK5.STU
- ISIN
- CH0011432447
- Exchange
- Stuttgart Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- Website
- -
About BASILEA PHARMACEU N (PK5.SG)
There is no Profile data available for PK5.SG.